Las Vegas, NV -- (SBWIRE) -- 09/27/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Magnum Hunter Resources Corp (NYSE:MHR), Sequenom, Inc. (NASDAQ:SQNM), Zoltek Companies, Inc.(NASDAQ:ZOLT), BioScrip Inc(NASDAQ:BIOS)
Magnum Hunter Resources Corp (NYSE:MHR) managed to keep its gain at 7.51% on above-normal volume of 4.84M shares. The stock settled at $5.87 after floating in a range of $5.47 to $5.88. Its latest price has reached market capitalization of $1.01 Billion. Its 52-week range has been $2.37 to $5.88. Magnum Hunter Resources Corporation, an independent oil and gas company, engages in the exploration, exploitation, acquisition, development, and production of crude oil, natural gas, and natural gas liquid resources in the United States and Canada.
For How Long MHR will fight for Profitability? Read This Trend Analysis report
Sequenom, Inc.(NASDAQ:SQNM) traded up on a volume of 4.67 million, higher than its standard daily volume. Shares have gained 4.32% to $2.78. Over the last twelve months, the stock has lost-29.44% and faced a worst price of $2.58. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
For How Long SQNM’s Gloss will Attract Investors? Find out via this report
Zoltek Companies, Inc. (NASDAQ:ZOLT) settled 12.66% higher at $18.51 on above-normal volume of 4.59M shares during the last trading day. The stock has its 12-month high at $19.09 and 52-week low price was $6.02. It traded in a range of $16.19 to $19.09 during the last trading day. Zoltek Companies, Inc., through its subsidiaries, develops, manufactures, and markets carbon fibers and technical fibers primarily in the United States, Europe, and Asia.
Why Should Investors Buy ZOLT After the Recent Fall? Just Go Here and Find Out
In the last trading session, BioScrip Inc (NASDAQ:BIOS) was down on high volume, trading at a volume of 4.41M versus its average daily volume of 1.66 million shares. At $8.78, the stock has attained market capitalization of 596.10 million. BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States.
Why Should Investors Buy BIOS After the Recent Fall? Just Go Here and Find Out
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The Equity Observer Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)